Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Eye Care

Journal Scan / Research · September 26, 2022

Expert Consensus on the Use of Teprotumumab for the Management of Patients With Thyroid Eye Disease

Journal of Neuro-Ophthalmology


Additional Info

Journal of Neuro-Ophthalmology
Expert Consensus on the Use of Teprotumumab for the Management of Thyroid Eye Disease Using a Modified-Delphi Approach
J Neuroophthalmol 2022 Sep 01;42(3)334-339, RS Douglas, AL Kossler, J Abrams, CA Briceño, D Gay, A Harrison, M Lee, J Nguyen, SS Joseph, D Schlachter, J Tan, J Lynch, L Oliver, R Perry, S Ugradar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading